| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |